Promising avenues could simplify glaucoma management – just in time
Innovative therapies scale up to meet needs of a growing patient population
OrthoK lenses: Possible long-term axial length shortening for myopic patients
Patient age is significant in the long-term effect of orthokeratology lenses
Researchers present new monitoring option for intermediate uveitis
Optical coherence tomography angiography could also identify patients at risk of disease progression
Sight Sciences announces European launch of OMNI Surgical System Ergo-Series
The company made its CE Mark announcement during the ESCRS Winter Meeting
Listening to the heart: Lessons from cardiology in remote monitoring and AI
Physicians explore how other specialties adopt and integrate remote monitoring
Beacon Therapeutics shares 12-Month Data from Phase 2 SKYLINE trial of AGTC-501 for patients with XLRP
The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024
US FDA grants OKYO Pharma approval of IND for neuropathic corneal pain therapy OK-101
The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP
Optica releases data on spiral diopter lens developed for multifocal vision correction
The technology has potential for applications in contact lenses and intraocular implants
Iridex Corporation receives European patent on MicroPulse technology
According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields
UCL and Moorfields Eye Hospital receive £5 million toward eye health research facility Oriel
An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027
Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye
Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images
Extracellular vesicles could be the future of retinal diseases
How this treatment paradigm could change ocular cell therapy
Angiogenesis 2024: Highlighting 72-week results from the BALATON and COMINO Phase 3 studies of faricimab in retinal vein occlusion
Ramin Tadayoni, MD, PhD, highlights data from the BALATON and COMINO Phase 3 studies about faricimab
Voyager study provides data on real-world effectiveness of faricimab for nAMD and DME
Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference
Angiogenesis 2024: Targeting Ang2 and VEGF – Biology, Pharmacokinetics and Latest Clinical Data in nAMD and DME
Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design
Angiogenesis 2024: The implication of longitudinal AI-based fluid quantification for at-home monitoring
Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis
Angiogenesis 2024: Findings from the DAVIO 2 trial, assessing EYP-1901 vs aflibercept for wet AMD
Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data
Angiogenesis 2024: Expanded efficacy data from the GATHER 2 trial
Sydney M Crago, editor of Modern Retina, talks with Arshad M Khanani, MD, MA, FASRS, about the expanded efficacy data from the GATHER 2 trial, presented at the 2024 Angiogenesis Symposium
Angiogenesis 2024: Distinguishing aspects of early-onset AMD
EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants
Multimodal assessment of OCT adds perspective on GA and AMD progression
Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging
Kiora Pharmaceuticals and Théa Open Innovation announce partnership, will target IRDs
Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases
Case report: diversifying cataract outcomes
Many options with one single Nd:YAG laser
AI ocular screenings facilitate early intervention for paediatric patients
Enhanced detection and diagnosis of common and severe diseases
How biosimilars expand treatment options for patients with retinal disease
An in-depth case study conversation
What do you do when there is no cataract?
Standalone, minimally-invasive glaucoma treatments
Plan your day: afternoon sessions at the Angiogenesis, Exudation, and Degeneration 2024 Conference
The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting
Angiogenesis, Exudation and Degeneration Conference: A 1-day virtual symposium of all things retina
The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System
Iridex and Imperial College Healthcare NHS Trust announce collaborative MicroPulse TLT study
The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)
Corneas harvested from patients who died of drowning are viable for transplantation
Postoperative outcomes of the tissues obtained from these donors were satisfactory
Intra-anterior chamber anti-VEGF injections feasible treatment for advanced paediatric vitreoretinal diseases
Investigators advised that further studies should be conducted to understand more precisely the benefits and risks
